HCW Biologics (HCWB) Interest Coverage Ratio (2022 - 2026)
HCW Biologics' (HCWB) quarterly Interest Coverage Ratio came in at 31.49 in Q2 2026, down 107.93% on a YoY basis from 397.24 in Q2 2025, and down 49.72% quarter-over-quarter from 21.03 in Q4 2025.
Powered by 
Analysis
HCW Biologics (HCWB) Interest Coverage Ratio (2022 - 2026) Analysis & Trends
HCW Biologics (HCWB) has reported Interest Coverage Ratio for 5 consecutive years, with 31.49 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Interest Coverage Ratio fell 107.93% year-over-year to 31.49; the trailing twelve-month figure through Jun 2026 stood at 21.52 (down 70.93% YoY), and the FY2025 full-year result was 15.58, up 65.4% from the prior year.
- Interest Coverage Ratio fell to 31.49 in Q2 2026 per HCWB's latest filing, from 21.03 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 7567.25 in Q4 2023 and bottomed at 124.9 in Q3 2022.
- Historically, Interest Coverage Ratio has averaged 500.03 across 5 years, with a median of 28.7 in 2025.
- The sharpest annual moves came in 2023 and 2026: Interest Coverage Ratio surged 12715.02% in 2023, then plunged 107.93% in 2026.
- Over 5 years, Interest Coverage Ratio stood at 59.99 in 2022, then jumped by 12715.02% to 7567.25 in 2023, then sank by 100.16% to 12.09 in 2024, then sank by 74.0% to 21.03 in 2025, then tumbled by 49.72% to 31.49 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 31.49, 21.03, and 25.91 for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.84 Bn | 192.85 Bn | 7.24 Bn | 5.22 |
| 2 | Gilead Sciences | 180.29 Bn | 177.11 Bn | 6.22 Bn | -42.08 |
| 3 | Vertex Pharmaceuticals | 131.27 Bn | 123.42 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.95 Bn | 73.96 Bn | 3.93 Bn | 117.59 |
| 5 | Argenx Se | 60.32 Bn | 55.13 Bn | 1.37 Bn | 493.00 |
| 6 | Moderna | 53.94 Bn | 48.80 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.35 Bn | 30.04 Bn | 992.69 Mn | 2.82 |
| 8 | Biogen | 31.85 Bn | 30.56 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.08 Bn | 29.08 Bn | 1.16 Mn | - |
| 10 | HCW Biologics | 3.24 Mn | 2.50 Mn | -93,887.00 | -31.49 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -31.49 |
| Dec 31, 2025 | -21.03 |
| Sep 30, 2025 | -25.91 |
| Jun 30, 2025 | -15.15 |
| Mar 31, 2025 | -7.68 |
| Dec 31, 2024 | -12.09 |
| Sep 30, 2024 | -16.09 |
| Jun 30, 2024 | -94.80 |
| Dec 31, 2023 | 7,567.25 |
| Sep 30, 2023 | -53.16 |
| Jun 30, 2023 | -47.22 |
| Mar 31, 2023 | -57.37 |
| Dec 31, 2022 | -59.99 |
| Sep 30, 2022 | -124.90 |